Literature DB >> 25715106

Evaluating potential T-cell epitope peptides for detecting HIV-specific T cell responses in a highly diverse HIV-1 epidemic from Cameroon.

Marcel Tongo1,2,3, Catherine Riou1, Eléonore Crunchant1, Tracey L Müller1, Natalie Strickland1, Eitel Mpoudi-Ngole2, Wendy A Burgers1.   

Abstract

HIV genetic diversity is a major obstacle for vaccine development. To define whether potential T-cell epitope (PTE) peptide usage improves the detection of T cell responses in a highly diverse HIV-1 epidemic, we compared the magnitude, breadth and depth of group M PTE peptide responses to consensus M peptides in Gag and Nef proteins. Gag PTE responses were detected at a higher magnitude, more Nef PTE responses were detected at a cohort (but not individual) level and depth was detected in both Gag and Nef responses.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25715106      PMCID: PMC4374151          DOI: 10.1097/QAD.0000000000000581

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  13 in total

1.  Polyvalent vaccines for optimal coverage of potential T-cell epitopes in global HIV-1 variants.

Authors:  Will Fischer; Simon Perkins; James Theiler; Tanmoy Bhattacharya; Karina Yusim; Robert Funkhouser; Carla Kuiken; Barton Haynes; Norman L Letvin; Bruce D Walker; Beatrice H Hahn; Bette T Korber
Journal:  Nat Med       Date:  2006-12-24       Impact factor: 53.440

2.  Web-based design and evaluation of T-cell vaccine candidates.

Authors:  James Thurmond; Hyejin Yoon; Carla Kuiken; Karina Yusim; Simon Perkins; James Theiler; Tanmoy Bhattacharya; Bette Korber; Will Fischer
Journal:  Bioinformatics       Date:  2008-05-29       Impact factor: 6.937

3.  Enhanced detection of human immunodeficiency virus type 1 (HIV-1) Nef-specific T cells recognizing multiple variants in early HIV-1 infection.

Authors:  Uma Malhotra; Fusheng Li; Jessica Nolin; Megan Allison; Hong Zhao; James I Mullins; Steve Self; M Juliana McElrath
Journal:  J Virol       Date:  2007-02-28       Impact factor: 5.103

4.  Mosaic HIV-1 vaccines expand the breadth and depth of cellular immune responses in rhesus monkeys.

Authors:  Dan H Barouch; Kara L O'Brien; Nathaniel L Simmons; Sharon L King; Peter Abbink; Lori F Maxfield; Ying-Hua Sun; Annalena La Porte; Ambryice M Riggs; Diana M Lynch; Sarah L Clark; Katherine Backus; James R Perry; Michael S Seaman; Angela Carville; Keith G Mansfield; James J Szinger; Will Fischer; Mark Muldoon; Bette Korber
Journal:  Nat Med       Date:  2010-02-21       Impact factor: 53.440

5.  Mosaic vaccines elicit CD8+ T lymphocyte responses that confer enhanced immune coverage of diverse HIV strains in monkeys.

Authors:  Sampa Santra; Hua-Xin Liao; Ruijin Zhang; Mark Muldoon; Sydeaka Watson; Will Fischer; James Theiler; James Szinger; Harikrishnan Balachandran; Adam Buzby; David Quinn; Robert J Parks; Chun-Yen Tsao; Angela Carville; Keith G Mansfield; George N Pavlakis; Barbara K Felber; Barton F Haynes; Bette T Korber; Norman L Letvin
Journal:  Nat Med       Date:  2010-02-21       Impact factor: 53.440

6.  Striking lack of T cell immunodominance in both a multiclade and monoclade HIV-1 epidemic: implications for vaccine development.

Authors:  Marcel Tongo; Lycias Zembe; Eugenie Ebong; Surita Roux; Linda-Gail Bekker; Carolyn Williamson; Eitel Mpoudi-Ngole; Wendy A Burgers
Journal:  Vaccine       Date:  2014-03-02       Impact factor: 3.641

7.  Increased breadth and depth of cytotoxic T lymphocytes responses against HIV-1-B Nef by inclusion of epitope variant sequences.

Authors:  Morgane Rolland; Nicole Frahm; David C Nickle; Nebojsa Jojic; Wenjie Deng; Todd M Allen; Christian Brander; David E Heckerman; James I Mullins
Journal:  PLoS One       Date:  2011-03-28       Impact factor: 3.240

8.  Intra- and inter-clade cross-reactivity by HIV-1 Gag specific T-cells reveals exclusive and commonly targeted regions: implications for current vaccine trials.

Authors:  Lycias Zembe; Wendy A Burgers; Heather B Jaspan; Linda-Gail Bekker; Helba Bredell; Gwynneth Stevens; Jill Gilmour; Josephine H Cox; Patricia Fast; Peter Hayes; Eftyhia Vardas; Carolyn Williamson; Clive M Gray
Journal:  PLoS One       Date:  2011-10-12       Impact factor: 3.240

9.  Characterization of HIV-1 gag and nef in Cameroon: further evidence of extreme diversity at the origin of the HIV-1 group M epidemic.

Authors:  Marcel Tongo; Darren P Martin; Lycias Zembe; Eitel Mpoudi-Ngole; Carolyn Williamson; Wendy A Burgers
Journal:  Virol J       Date:  2013-01-22       Impact factor: 4.099

10.  Coping with viral diversity in HIV vaccine design.

Authors:  David C Nickle; Morgane Rolland; Mark A Jensen; Sergei L Kosakovsky Pond; Wenjie Deng; Mark Seligman; David Heckerman; James I Mullins; Nebojsa Jojic
Journal:  PLoS Comput Biol       Date:  2007-04-27       Impact factor: 4.475

View more
  2 in total

Review 1.  Challenges in the design of a T cell vaccine in the context of HIV-1 diversity.

Authors:  Marcel Tongo; Wendy A Burgers
Journal:  Viruses       Date:  2014-10-23       Impact factor: 5.048

2.  Near full-length HIV type 1M genomic sequences from Cameroon : Evidence of early diverging under-sampled lineages in the country.

Authors:  Marcel Tongo; Jeffrey R Dorfman; Melissa-Rose Abrahams; Eitel Mpoudi-Ngole; Wendy A Burgers; Darren P Martin
Journal:  Evol Med Public Health       Date:  2015-09-09
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.